© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Griseofulvin shows up as a well-known antifungal agent, used mainly for treating fungal infections of the skin, hair, and nails. Derived from the mold Penicillium griseofulvum, the compound stands out for its unique action against dermatophytes, which are a group of fungi causing tough skin diseases. I first learned about Griseofulvin at university in a pharmacology class, but its importance hit home years later when a close friend struggled with a persistent ringworm infection that nothing else seemed to resolve. Doctors prescribed Griseofulvin, and the infection cleared up faster than with the topical creams alone. The real-world impact of this molecule makes its story relevant beyond textbooks.
Griseofulvin’s molecular formula reads as C17H17ClO6; its systematic structure brings a flavor of complexity, showing fused rings and a chlorine atom attached at a specific position. Its molecular weight clocks in near 352.8 g/mol. Anyone handling the raw material will recognize its form—it presents itself as a white to pale yellow crystalline powder, often described as odorless or very faintly earthy. The product’s melting point stays around 220–225°C. Water solubility remains very low (less than 10 mg/L at room temperature), which explains why the substance often gets formulated with enhancing agents or carried in suspension or solution for intake. The density of Griseofulvin powder sits close to 1.5 g/cm3.
Raw Griseofulvin can turn up as dense powder, loose flakes, or tiny crystals, depending on the refining and processing. In my early days working in a pharmacy storeroom, I opened containers of Griseofulvin that seemed like flour, but I’ve also seen it in solid pressed pellets for industrial use. The flakes shimmer faintly under light, while the crystalline form breaks up under pressure like a dry biscuit. Pearled and liquid forms stay rare, since the compound’s chemical nature doesn’t lend itself to liquid solutions unless suspended in suitable solvents. Solutions containing Griseofulvin often come in low concentrations, due to its low solubility in both water and many organic solvents. Bulk density varies by grade and granulation but rarely strays far from published values.
The backbone of Griseofulvin features a benzofuran ring fused to a cyclohexene and dihydropyran rings. The presence of chlorine adds both chemical stability and a specific activity against target fungal cell components—fungal microtubules, specifically. In practical applications, this precise attack on microtubules means Griseofulvin interrupts cell division in fungi without hurting human cells at recommended dosages. The molecule is not volatile, doesn’t sublimate, and shows strong resistance to most weak acids. It reacts slightly under strong bases and intense sunlight, which influences storage conditions.
For customs and trade, Griseofulvin falls under H.S. Code 2933.29, which covers heterocyclic compounds containing an unfused furan ring. Manufacturing plants and labs shipping the raw material between countries mark this code on all consignment notes and customs paperwork, ensuring smooth transit. In discussions with customs brokers, it’s clear that mismarking an HS code can bring shipments to a halt, delay projects, and increase costs, so knowledge of precise classification saves both time and money for importers and exporters.
Griseofulvin carries risks that come with any bioactive chemical. Inhalation of raw powder can irritate the respiratory system; long-term or excessive exposure sometimes leads to allergic responses or, rarely, more severe systemic effects. While the medication plays a therapeutic role inside the body, handling the pure chemical raw material calls for gloves, dust masks, and good ventilation. Animal studies used in toxicology indicate that high prolonged doses increase risk of liver toxicity and, in rare cases, the material shows carcinogenic effects in laboratory settings. Storage requires a cool, dry environment, shielded from light and humidity, preferably in high-density polyethylene or glass containers labeled as hazardous chemical raw material. Spills of powder must get cleaned promptly with damp cloths, not swept dry, which just disperses the fine dust.
Most of the world’s Griseofulvin production relies on fermentation of Penicillium griseofulvum or Penicillium nigricans cultures. Growing up near a biotech plant, I saw first-hand the massive steel fermenters and complex filtration systems needed for pharmaceutical-grade purification. Low-quality or impure raw material means less predictable efficacy and higher side effects risk, so strong sourcing controls stay necessary. Authentication methods like HPLC (High-Performance Liquid Chromatography) remain standard at every stage from fermentation to finished product. Laboratories or manufacturers looking to buy Griseofulvin must request a certificate of analysis and sometimes extra purity tests, since contamination by other natural metabolites can undercut both quality and legal compliance.
Modern regulation demands traceability for all raw materials entering pharmaceuticals, and Griseofulvin keeps a spot on many priority lists, given both its effectiveness and potential hazards in raw form. It’s up to every handler—from the biochemist in the lab to the logistics manager at a shipping dock—to understand how a white powder in a container transforms into a safe, life-altering medicine after precise testing, validation, and strict storage controls. Beyond requirements, the story of Griseofulvin speaks to how rigorous chemical and biological knowledge, paired with economic and regulatory vigilance, can turn a natural molecule into an essential clinical tool while keeping workers and patients out of harm’s way.
